Hyperoxic acute lung injury

Respiratory Care

Volumn 58, Issue 1, 2013, Pages 123-140

  Kallet, Richard H ^a   Matthay, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Hyperoxia; Oxygen toxicity; Reactive oxygen species; Ventilator induced lung injury

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 8; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE;

ACCLIMATIZATION; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; ARTIFICIAL VENTILATION; BLOOD OXYGEN TENSION; CELL DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; GENETIC PREDISPOSITION; HUMAN; HYPEROXIA; INJURY SEVERITY; LONG TERM CARE; LONG TERM EXPOSURE; MORTALITY; NONHUMAN; OXYGEN CONCENTRATION; OXYGEN THERAPY; OXYGEN TOXICITY; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; TIDAL VOLUME;

ACUTE LUNG INJURY; ANIMALS; CYTOKINES; HUMANS; HYPEROXIA; OXYGEN; OXYGEN INHALATION THERAPY; PARTIAL PRESSURE; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 84873661506     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01963     Document Type: Conference Paper

References (115)

1. Bean JW. Effects of O2 at increased pressure. Physiol Rev 1945; 25(1):1-147.
2. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, et al. Hyperoxia causes angiopoietin-2 mediated acute lung injury and necrotic cell death. Nat Med 2006;12(11):1286-1293.
3. Ohlsson WTL. A study on O2 toxicity at atmospheric pressure with special reference to the pathogenesis of pulmonary damage and O2 O2 therapy. Acta Med Scand 1947;190(Suppl):4-89.
4. Smith JL. The pathological effects due to increase of O2 tension in the air breathed. J Physiol 1899;24(1):19-35.
5. Clark JM, Lambertsen CJ. Pulmonary O2 toxicity: a review. Pharmacol Rev 1971;23(2):37-133.
6. Hill L. Caisson sickness and compressed air-1. Scientific American 1911;1868(Suppl):270-271.
7. Friedrich M, Grayzel DM. High resistance of rhesus monkeys to 90+ percent O2. Proc Soc Exp Biol Med 1944;56:204-205.
8. Kaplan HP, Robinson FR, Kapanci Y, Weibel ER. Pathogenesis and reversibility of the pulmonary lesions of O2 toxicity and monkeys. Lab Invest 1969;20(1):94-99.
9. Ciencewicki J, Trivedia S, Kleeberger SR. Oxidants in the pathogenesis of lung diseases. J Allergy Clin Immunol 2008;122(3):456-468.
10. Parad R, Simmons G, Feldman N, Huber G. Impairment of adaptive tolerance to O2 toxicity by systemic immunosuppression. Chest 1975;67(Suppl 2):42-43.
11. Crapo JD, Barry BE, Froscue HA, Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 1980; 122(1):123-143.
12. Huang Y-C, Caminiti SP, Fawcett TA, Moon RE, Fracica PF, Miller FJ, et al. Natural surfactant and hyperoxia in primates. I. Physiology and biochemistry. J Appl Physiol 1994;76(3):991-1001.
13. Robinson FR, Harper DT, Thomas AA, Kaplan HP. Proliferative pulmonary lesions and monkeys exposed to high concentrations of O2. Aerosp Med 1967;38(5):481-486.
14. Wolfe WG, Robinson LA, Moran JF, Lowe JE. Reversible pulmonary O2 toxicity in the primate. Ann Surg 1978;188(4):530-543.
15. de Los Santos R, Coalson JJ, Holcomb JR, Johanson WG. Hyperoxia exposure in mechanically ventilated primates with and without previous lung injury. Exp Lung Res 1985;9(3-4):255-275.
16. Hyde RW, Rawson AJ. Unintentional iatrogenic O2 pneumonitis: response to therapy. Ann Intern Med 1969;71(3):517-531.
17. Comroe JH, Dripps RD, Dumke PR, Deming N. Oxygen toxicity. JAMA 1945;128(10):710-717.
18. Tierney DF, Ayres L, Kasuyama RS. Altered sensitivity to O2 toxicity. Am Rev Respir Dis 1977;115(6):59-65.
19. Smith G, Winter PM, Wheelis RF. Increased normobaric O2 tolerance of rabbits following oleic acid-induced lung damage. J Appl Physiol 1973;35(3):395-400.
20. Hakkinen PJ. Morse CC, Martin FM, Dalbey WE, Haschek WM, Witsch HR. Potentiating effects of oxygen in lungs damaged by methylcyclopentadienyl manganese tricarbonyl, cadmium chloride, oleic acid and antitumor drugs. Toxicol Appl Pharmacol 1983; 67(1):55-69.
21. Winter PM, Smith G, Wheelis RF. The effect of prior pulmonary injury on the rate of development of fatal O2 toxicity. Chest 1974; 66(1):1S-4S.
22. Thiel M, Chrouker A, Ohta A, Jackson E, Caldwell C, Smith P, et al. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbate acute laboratory lung injury. PLoS Biol 2005;3(6):1088-1100.
23. Pratt PC. The reaction of the human lung to enriched O2 atmosphere. Ann NY Acad Sci 1965;121:809-822.
24. Quinn DA, Moufarrej RK, Volokhov A, Hales CA. Interactions of the lung stretch, hyperoxia, MIP-2 production in ventilator-induced lung injury J Appl Physiol 2002;93(2):517-525.
25. Bailey TC, Martin EL, Xiao L, Veldhurizen RAW. High oxygen concentrations predisposed mouse lungs to the deleterious effects of high stretch ventilation. J Appl Physiol 2003;94(3):975-982.
26. Sinclair SE, AltemeierWA, Matute-Bello G. Augmented lung injury due to interaction between hyperoxia and mechanical ventilation. Crit Care Med 2004;32(12):2496-2501.
27. Makena PS, Luellen CL, Balazes L, Ghosh MC, Parthasarathi K, Waters CM, Sinclair SE. Preexposure to hyperoxia causes increased lung injury and epithelial apoptosis in mice ventilated with high VTs. Am J Physiol Lung Cell Mol Physiol 2010;299(5):L711-L719.
28. Makena PS, Gorantla VK, Ghosh MC, Bezawada L, Balazes L, Luellen CL, et al. Lung injury caused by high VT mechanical ventilation and hyperoxia is dependent on oxidant-mediated c-Jun NH2-terminal kinase activation. J Appl Physiol 2011;111(5):1467-1476.
29. Liu Y-Y, Liao S-K, Tsai Y-H, Quinn DA, Li L-F. Role for nuclear factor-kB in augmented lung injury because of interaction between hyperoxia and high stretch ventilation. Transl Res 2009;154(5): 228-240.
30. Li L-F, Liao S-K, Lee C-H, Quinn DA. Hyperoxia increases ventilator-induced lung injury by mitogen-activated protein kinases: a prospective, controlled animal experiment. Crit Care 2007;11(1): R25.
31. de Los Santos R, Seidenfeld JJ, Anzueto A, Collins JF, Coalson JJ, Johanson WG, Peters JI. One hundred percent O2 lung injury in adult baboons. Am Rev Respir Dis 1987;136(3):657-661.
32. Balentine JD. Pathologic effects of exposure to high O2 tensions. N Engl J Med 1966;275(19):1038-1040.
33. Jackson RM. Pulmonary oxygen toxicity. Chest 1985;88(6):900-905.
34. Deneke SM, Fanburg BL. Normobaric oxygen toxicity of the lung. N Engl J Med 1980;303(2):76-86.
35. Altemeier WA, Sinclair SE. Hyperoxia in the intensive care unit: why more is not always better. Curr Opin Crit Care 2007;13(1): 73-78.
36. Tateda K, Deng JC, Moore TA, Newstead MW, Paine R, Kobayashi N. Hyperoxia mediates acute lung injury and increased lethality in murine legionella pneumonia: the role of apoptosis. J Immunol 2003;170(8):4209-4216.
37. Kikuchi Y, Tateda K, Fuse ET, Matsumato T, Gotoh N, Fukushima J, et al. Hyperoxia exaggerates bacterial dissemination, and lethality and Pseudomonas aeruginosa pneumonia. Pulm Pharmacol Ther 2009;22(4):333-339.
38. Gore A, Muralidhar M, Espey MG, Degenhardt K, Lin LM. Hyperoxia sensing: from molecular mechanisms to significance in disease. J Immunotoxicol 2010;7(4):239-254.
39. Fracica PJ, Knapp MJ, Piantadosi CA, Takeda K, Fulkerson WJ, Coleman RE, et al. Responses of baboons to prolonged hyperoxia: physiology and qualitative pathology. J Appl Physiol 1991;71(6): 2352-2362.
40. Rogers J, Katze M, Bumgarner R, Gibbs RA, Weinstock GM. White paper for complete sequencing of the rhesus macaque (Macaca mullata) genome. http://www.genome.gov/pages/research/sequenc ing/seqproposals/rhesusmacaqueseq021203.pdf. Accessed October 25, 2012.
41. Weir FW, Bath DW, Yevich P, Oberst FW. Study of effects of continuous inhalation of high concentrations of oxygen at ambient pressure and temperature. Aerospace Med 1965;36(2):117-120.
42. Robinson FR, Sopher RL, Witchett SC, Carter VL. Pathology of normobaric oxygen toxicity in primates. Aerospace Med 1969;40(8): 879-884.
43. Diamond J. The third chimpanzee. The evolution and future of the human animal. New York: Harper Collins; 1992:21.
44. Kafer ER. Pulmonary O2 toxicity. Br J Anaesth 1971;43(7):687-695.
45. Cedergreen B, Gyllensten L, Wersall J. Pulmonary damage caused by oxygen poisoning. Acta Paediat Scand 1959;48:477-452.
46. Castleman B, McNeely BU. Case records of the Massachusetts General Hospital. Case 7-1967. N Engl J Med 1967;276(7):401-411.
47. Pratt PC. Pulmonary capillary proliferation induced by O2 ventilation. Am J Pathol 1958;34(6):1033-1050.
48. Gerschman D, Gilbert DL, Nye SW, Dwyer P, Fenn WO. Oxygen poisoning and X irradiation: a mechanism in common. Science 1954;119(3097):623-625.
49. Capers TH. Pulmonary hyaline membrane formation in the adult. Am J Med 1961;31(5):701-710.
50. Cederberg A, Hellsten S, Miorner G. O2 treatment and hyaline pulmonary membranes in adults. Acta Pathol Microbiol Scand 1965; 64(4):450-458.
51. Fuson RL, Saltzman HA, Smith WW, Whalen RE, Osterhout S, Parker RT. Clinical hyperbaric oxygenation with severe O2 toxicity. N Engl J Med 1965;273(8):415-419.
52. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. N Engl J Med 1967;276(7):257-368.
53. Nash G, Blennerhassett JB, Pontoppidan H. Pulmonary lesions associated with O2 therapy and artificial ventilation. N Engl J Med 1967;276(7):368-374.
54. Pratt PC. O2 toxicity as a factor. J Trauma 1968;8(5):854-866.
55. Barter RA, Finley-Jones LR, Walters M. Pulmonary hyaline membrane: sites information in adult longs after assisted respiration and inhalation of O2. J Pathol Bacteriol 1968;95(2):481-487.
56. Soloway HB, Castillo Y, Martin AM. Adult hyaline membrane disease: relationship to O2 therapy. Ann Surgery 1968;168(6):937-945.
57. Joffe N, Simon M. Pulmonary O2 toxicity in the adult. Radiology 1969;92(3):460-465.
58. Greenberg SD, Gyorkey F, O'Neal RM. Pulmonary hyaline membranes in adults receiving O2 therapy. Tex Rep Bio Med 1969; 27(4):1005-1012.
59. Brewis RA. O2 toxicity during artificial ventilation. Thorax 1969; 24(6):656-665.
60. Rowland R, Newman CG. Pulmonary complications of O2 therapy. J Clin Pathol 1969;22(2):192-198.
61. Gutierrez VS, Berman IR, Soloway HB, Hamit HF. Relationship of hypoproteinemia and prolonged mechanical ventilation to the development of pulmonary insufficiency in shock. Ann Surg 1970; 171(3):385-393.
62. Singer MM, Wright F, Stanley LK, Roe BB, Hamilton WK. O2 toxicity in man: a prospective study in patients after open-heart surgery. N Engl J Med 1970;283(27):1473-1478.
63. Barber RE, Lee J, Hamilton WK. O2 toxicity in man: a prospective study in patients with irreversible brain damage. N Engl J Med 1970;283(27):1478-1484.
64. Senior RM, Wessler S, Avioli LV. Pulmonary O2 toxicity. JAMA 1971;217(10):1373-1377.
65. 2 pneumonitis in man. Ultrastructural observations on the development of alveolar lesions. Lab Invest 1972;26 5):499-508.
66. Sevitt S. Diffuse and focal O2 pneumonitis. J Clin Pathol 1974; 27(1):21-30.
67. Katzenstein A-L, Bloor CM, Leibow AA. Diffuse alveolar damage: the role of O2, shock, and related factors. Am J Pathol 1976;85(1): 210-223.
68. Farber S, Wilson JL. The hyaline membranes in the lungs. Arch Path 1932;14:437-460.
69. Barry JM. The great influenza. The epic story of the deadliest plague in history. New York: Viking; 2004:250-251.
70. Linton RC, Walker FW, Spoerel WE. Respirator care in a general hospital. A five-year survey. Can Anaesth Soc J 1965;12(5):450-457.
71. Nash G, Bolan JA, Langlinais PC. "Respirator lung": a misnomer. Arch Pathol 1971;21(3):234-240.
72. De Lemos R, Wolfsdorf J, Nachman R, Block AJ, Leiby G, Wilkinson HA, et al. Lung injury from O2 in lambs: the role of artificial ventilation. Anesthesiology 1969;30(6):609-618.
73. Greenfield LJ, Ebert PA, Benson DW. Effect of positive pressure ventilation and surface tension properties of lung extracts. Anesthesiology 1964;25(3):312-316.
74. Pontoppidan H. Hedley-Whyte J, Bendixen HH, Laver MB, Radford EP. Ventilation and O2 requirements during prolonged artificial ventilation in patients with respiratory failure. N Engl J Med 1965;273(8):401-409.
75. Davis JM, Penney DP, Notter RH, Metlay L, Dickenson B, Shapiro DL. Lung injury in the neonatal piglet caused by hyperoxia and mechanical ventilation. J Appl Physiol 1989;67(3):1007-1012.
76. Van Kaam A. Lung-protective ventilation in neonatalogy. Neonatalogy 2011;99(4):338-341.
77. Fairley HB, Britt BA. The adequacy of the air-mix control in ventilators operated from an O2 source. Can Med Assoc J 1964;90: 1394-1396.
78. Pontoppidan H. Berry PR. Regulation of the inspired O2 concentration during artificial ventilation. JAMA 1967;201(1):89-92.
79. Jain KK. Oxygen toxicity. In Jain KK: The textbook of hyperbaric medicine. 5th edition. Cambridge: Hogrefe; 2009:48-58.
80. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;12(2):319-323.
81. Blaisdell FW, Lim RC, Stallone RJ. The mechanism of pulmonary damage following traumatic shock. Surg Gynecol Obstet 1970; 130(1):15-22.
82. Powers SR, Burdge R, Leather R, Monaco V, Newall J, Sardur S, Smith EJ. Studies of pulmonary insufficiency in non-thoracic trauma. J Trauma 1972;12(1):1-14.
83. Pontoppidan H, Geffen B, Lowenstein E. Acute respiratory failure in the adult (first of three parts). N Engl J Med 1972;287(14):690-698.
84. Murray JF; on behalf of the Division of Lung Diseases, National Heart, Lung and Blood Institute. Mechanisms of acute respiratory failure. Am Rev Respir Dis 1977;115(6):1071-1078.
85. Albert RK. Least PEEP: primum non nocere. Chest 1985;87(1):2-3.
86. NHLBI Acute Respiratory Distress Syndrome Network. Ventilation with lower VTs as a compared with traditional VTs for acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301-1308.
87. NHLBI Acute Respiratory Distress Syndrome Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351(4): 327-336.
88. Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med 1998;338(6):355-361.
89. Brochard L, Roudot-Thoraval F, Roupie E, Delclaux C, Chastre J, Fernandez-Mondejar E, et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;158(6):1831-1838.
90. Villar J, Kacmarek RM, Perez-Mendez L, Aguirre-Jaime A, ARIES Network. A high positive end-expiratory pressure, low VT ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006; 34(5):1311-1318.
91. Mercat A, Richard J-CM, Vielle B, Jaber S, Osman D, Diehl J-L, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome. JAMA 2008; 299(6):646-655.
92. Petty TL, Stanford RE, Neff TA. Continuous oxygen therapy and chronic airway obstruction. Observations on possible. Oxygen toxicity and survival Ann Intern Med 1971;75(3):361-367.
93. Barbaro MPF, Servidedio G, Resta O, Rollo T, Tamborra R, Carpagnano GE, et al. Oxygen therapy at low flow causes oxidative stress and chronic obstructive pulmonary disease: prevention by N-acetylcysteine. Free Radic Res 2005;39(10):1111-1118.
94. Carvalho CRR, Schettino GPP, Maranhao B, Bethlem EP. Hyperoxia and lung disease. Curr Opin Pulm Med 1998;4(5):300-304.
95. Turrens JF. Mitochondrial formation of reactiveO2 species. J Physiol 2003;552(2):335-344.
96. Janssen YMW, Van Houten B, Borm PJA, Mossman BT. Biology of disease: cell and tissue responses to oxidative damage. Lab Invest 1993;69(3):61-274.
97. Brigham KL. Role of free radicals and lung injury. Chest 1986; 89(6):859-863.
98. Pagano A, Brazzazzone-Argiroffo C. Alveolar cell death in hyperoxia-induced lung injury. Ann NY Acad Sci 2003;1010:405-416.
99. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 1997;17(1):3-8.
100. Bast A, Weseler AR, Haenen GR, denHartog GJ. Oxidative stress and antioxidants in interstitial lung disease. Curr Opin Pul Med 2010;16(5):516-520.
101. Bhandari V, Elias JA. Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. Free Radic Biol Med 2006; 41(1):4-18.
102. Crapo JD, Freeman BA, Barry BE, Young SL. Mechanisms of hyperoxia injury to the pulmonary microcirculation. Physiologist 1983;26(3):170-175.
103. Kistler GS, Caldwell PRB, Weibel ER. Development of fine structural damage alveolar and capillary lining cells and O2-poisoned rat lungs. J Cell Biol 1967;32(3):605-628.
104. Barazzone C, Horowitz S, Donati YR, Rodriguez I, Piguet P-F. O2 toxicity and mouse lung: pathways to cell death. Am J Respir Cell Mol Biol 1998;19(4):573-581.
105. Harabin AL, Homer LD, Bradley ME. Pulmonary oxygen toxicity in awake dogs: metabolic and physiological effects. J Appl Physiol 1984;57(5):1480-1488.
106. Kapanci Y, Tosco R, Eggermann J, Gould VE. Oxygen pneumonitis in man. Chest 1972;62(2):162-169.
107. Barry BE, Crapo JD. Patterns of accumulation of platelets in neutrophils in rat lungs during exposure to hundred percent and 85% O2. Am Rev Respir Dis 1985;132(3):548-555.
108. Said SI. The lung as a metabolic organ. N Engl Med 1968;279(24): 1330-1334.
109. Hechtman HB, Shepro D. Lung metabolism and systemic organ function. Circ Shock 1982;9(4):457-467.
110. Toivonen H, Hartiala J, Bakhle YS. Effects of high oxygen tension on the metabolism of vasoactive hormones in isolated perfused rat lungs. Acta Physiol Scand 1981;111(2):185-192.
111. Allen BW, Demchenko IT, Piantadosi CA. Two faces of nitric oxide: implications for cellular mechanisms of O2 toxicity. J Appl Physiol 2009;106(4):662-667.
112. Tang PS, Mura M, Seth R, Liu M. Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol 2008;294(4):L632-L641.
113. Allen J, Cooper D, Fuller JM, McMinn KM, Culbreth RR. Modulation of monocyte chemotactic protein-1 production by hyperoxia: importance of RNA stability in control of cytokine production. Am J Respir Cell Mol Biol 1998;18(4):521-525.
114. Horowitz S. Pathways to cell death in hyperoxia. Chest 1999;116(1): 64S-67S.
115. Fisher AB, Beers MF. Hyperoxia and acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295(6):L1066.